Source: London and South East Regional Medicines Information Service
Area: Evidence > Reviews for Individual Funding Requests (IFRs)
Review completed for IFR panel September 2012 on Intravitreal bevacizumab for inflammatory choroidal neovascularisation secondary to punctate inner choroidopathy.
Uncategorized